Thank you!
Your support is sustaining the future of local news in our communities.

BD intensifies syringe output to meet U.S. demand amid China quality concerns

BD intensifies syringe output to meet U.S. demand amid China quality concerns

BD’s North Canaan plant has increased its output of syringes by more than 40% to meet the needs of U.S. healthcare customers after the FDA launched an ongoing investigation into quality issues with plastic syringes made in China.

Provided

NORTH CANAAN — Becton, Dickinson and Company (BD) has ramped up its production of syringes at its North Canaan plant in response to quality issues with plastic syringes imported from China which were uncovered late last year by the U.S. Food and Drug Administration (FDA).

BD, a leading global medical technology company and Northwest Connecticut’s largest employer, responded to the FDA’s recommendation that consumers, healthcare providers and healthcare facilities transition away from plastic syringes made in China by increasing its domestic manufacturing of syringes at the company’s Connecticut and Nebraska facilities.

Since January, BD’s 385,000-square-foot North Canaan plant has increased its output of syringes “by over 40% to meet the needs of U.S. healthcare customers,” according to Fallon McLoughlin, director of public relations and corporate communications for the Franklin Lakes, N.J.-based company.

“BD has achieved this increase by driving operational efficiencies and relocating some production lines from other BD plants,” said McLoughin.

“We’ve added over 100 full-time associates in the last year, and currently have more than 500 full-time associates and nearly 50 contingent associates,” she said of the North Canaan site, which began its operations in 1961 with eight employees at a 25,000-square-foot facility.

BD draws its employees from throughout Northwest Connecticut and neighboring New York.

McLaughlin noted that its Connecticut plant primarily manufactures small-size syringes, and syringe and needle combination products that are “critical to the delivery of healthcare.”

Operations take place around the clock, producing more than 2 billion medical devices each year that are sold in every region worldwide.

Responding to consumer needs

In March, Eric Borin, president of BD Medication Delivery Solutions, announced a statement saying: “BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care.”

Since the initial FDA safety communication in November 2023, he noted, “BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. Ensuring the safety and quality of our products is the top priority at BD.”

Borin further noted at the time that “The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system’s need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles to support the global pandemic response to COVID-19.”

Syringe manufacturers in China cited

In late November 2023, the FDA announced its probe into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China “that are used for injecting fluids into or withdrawing fluids from, the body,” according to the health regulator.

On March 14, the FDA issued an update on warning letters sent to three entities: Jiangsu Shenli Medical Production Co. Ltd, Medline Industries, LP and Sol-Millennium Medical Inc., describing violations related to the “sale and distribution of unauthorized plastic syringes that had not been cleared or approved by the FDA,” according to a new release.

“In addition, we are actively evaluating quality issues and performance testing failures with plastic syringes made by Jiangsu Caina Medical Co Ltd., a China-based manufacturer sited in the warning letter issued to Medline Industries, LP. The FDA will take additional steps as appropriate,” the FDA stated.

In its August 16 update, the FDA continued to recommend that healthcare providers “use syringes not manufactured in China, if possible.

“At this time, glass syringes, pre-filled syringes or syringes used for topical purposes are not included. If you only have syringes manufactured in China, then continue to use them as needed until you are able to use alternative syringes and closely monitor for leaks, breakage and other problems,” the FDA announced.

In March, BD was named to Fortune’s 2024 list of America’s Most Innovative Companies, and in September, the company announced that it had been named to TIME’s 2024 list of the World’s Best Companies based on employee feedback.

BD’s operations in North Canaan have also been recognized by the U.S. Environmental Protection Agency for achieving the Energy Star Challenge for Industry for energy reduction. The site is a landfill-free site where waste is reduced, recycled or converted into energy.

Latest News

“The Divine Sister” comes to Sharon Playhouse for one-night benefit
Playwright and performer Charles Busch is “The Divine Sister.”
Provided

Continuing a popular tradition, the Sharon Playhouse will present a one-performance-only staged reading of “The Divine Sister,” another riotous comic romp by the acclaimed playwright and performer Charles Busch, on Friday, Aug. 28 at 7 p.m.

The play is a wild and witty homage to Hollywood films that feature nuns — from “The Song of Bernadette” and “The Bells of St. Mary’s” to “The Singing Nun” and “The Sound of Music.” It is classic Charles Busch: wickedly funny, gloriously over-the-top and overflowing with theatrical joy.

Keep ReadingShow less

KK Kozik sees things differently

KK Kozik sees things differently

KK Kozik in her studio

Natalia Zukerman
Maybe it takes the ability to interpret what you’re looking at to really see.
— KK Kozik

KK Kozik has a theory about getting older.

“I don’t think you have eyes to see until you have eyes to see,” said the painter. “And maybe it takes the ability to interpret what you’re looking at to really see, and maybe that’s what comes with wisdom.”

Keep ReadingShow less
Lakeville Open Horse Show returns for 69th year

Jazzmine Bone and A Stitch in Tyme power through the Gambler’s Choice run during the 2024 Lakeville Open.

Caitlin Von Graf

For nearly seven decades, the Lakeville Open Horse Show has brought riders, horses and spectators together for a day of competition and community.

This year’s show takes place on Sunday, Aug. 30, at Riga Meadow at Coole Park, 1031 Bengal Amenia Road in Millbrook.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

A new home for contemporary music in Connecticut

This year, the ARChive of Contemporary Music, or ARC, is moving its collection to a permanent home in Ridgefield, Connecticut.

ARC is somewhat hard to imagine. Comprised mainly of huge collections from musicians, archivists, and DJs, it has compiled more than three million sound recordings, consisting of over 90 million songs.

Keep ReadingShow less
A Vietnamese water puppet musical returns to the quarry where it began

“The Magnificent Ms. Pham” combines Vietnamese water puppetry, shadow theater, music and storytelling.

Provided

“The Magnificent Ms. Pham,” the first Vietnamese American water puppet show, is returning to the water where it was born. The perpetual motion puppet show will be at TurnPark Art Space in West Stockbridge, Mass., Aug. 28 and 29, following a sold-out New York City premiere earlier this year. The production was originally developed at TurnPark, where its puppets first danced across the surface of the quarry lake.

Created by Vietnamese American artist Tommy Nguyen and director and designer Doug Fitch, the production tells the story of Nguyen’s mother, Kim Pham, and her journey from Vietnam to the United States. The story moves between memory, Vietnamese history and mythology, and the realities of immigration, following Kim from her childhood in Vietnam through her escape as a “boat person” and eventual life in Houston, Texas.

Keep ReadingShow less
Barry Blitt draws for the Northwest Connecticut Arts Council

Cartoonist Barry Blitt created a design for a limited edition T-shirt for Northwest Connecticut Arts Council fundraiser.

Jennifer Almquist

A drawing by Barry Blitt is recognizable from a distance simply for his line quality and hint of watercolor. Known for his scathing political cartoons, this longtime cover illustrator for the New Yorker has leaned his shoulder in to support the NWCT Arts Council and its Aug. 29 fundraiser at Buck’s Rock Camp in New Milford. Blitt created a design for limited-edition T-shirts that will be available for sale at the event and online at artsnwct.org.

David Remnick, editor of the New Yorker since 1998, called Blitt “One of the greatest political cartoonists of our time.” A native of Canada, Blitt won a Pulitzer Prize for editorial cartooning and has created more than 100 covers for the New Yorker since 1992. Perhaps most memorable is his 2008 iconic fist bump between Barack Obama and Michelle Obama, “The Politics of Fear.” A quarter century of his sketches and drawings are collected in “Blitt: In One Eye and Out the Other,” published by Penguin Putnam. He has created books for children, including “George Washington’s Birthday” and “Once Upon a Time, the End, (Asleep in 60 Seconds).”

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.